Stay updated with the latest - Click here to follow us on Instagram
The scientific committee advising the Drug Controller General of India (DCGI) met Saturday and took an in-principle decision to switch over to gelatin alternatives in capsules pending a final report on the matter.
The committee, comprising drug experts, was discussing the matter in the wake of the Bureau of Indian Standards (BIS) laying down standards for non-gelatin based capsules last month.
[related-post]
Gelatin, a colourless and brittle product, is obtained from the connective tissues, skin, bones, etc of animals, including pigs and cows, which are avoided by a majority of the country’s population because of religious reasons. It is the principal constituent of shells of capsules.
The Indian Express had reported about the BIS notification and the scheduled meeting of the scientific committee July 24.
The pharmaceutical industry, too, is positive about the replacement of gelatin, particularly because it had caused some issues for Indian pharma exports to the United States in the past.
A couple of years ago, the US had threatened to stop Indian drug imports because the bovine extracts used in them did not meet the standards laid down by the UDFDA.
Stay updated with the latest - Click here to follow us on Instagram